What is the share price of Astonea Labs Ltd (ASTONEALAB) today?
The share price of ASTONEALAB as on 21st September 2026 is ₹344.50. The stock prices are volatile and keep changing through the day depending upon various factors and market conditions.What is the return on Astonea Labs Ltd (ASTONEALAB) share?
The past returns of Astonea Labs Ltd (ASTONEALAB) share are- Past 1 week: 16.78%
- Past 1 month: 23.92%
- Past 3 months: 28.57%
- Past 6 months: 124.43%
- Past 1 year: 99.77%
- Past 3 years: N/A%
- Past 5 years: 153.96%
What are the peers or stocks similar to Astonea Labs Ltd (ASTONEALAB)?
The peers or stocks similar to Astonea Labs Ltd (ASTONEALAB) include:What is the market cap of Astonea Labs Ltd (ASTONEALAB) share?
Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Astonea Labs Ltd (ASTONEALAB) is ₹362.10 Cr as of 21st September 2026.What is the 52 week high and low of Astonea Labs Ltd (ASTONEALAB) share?
The 52-week high of Astonea Labs Ltd (ASTONEALAB) is ₹369 and the 52-week low is ₹118.What is the PE and PB ratio of Astonea Labs Ltd (ASTONEALAB) stock?
The P/E (price-to-earnings) ratio of Astonea Labs Ltd (ASTONEALAB) is 80.29. The P/B (price-to-book) ratio is 6.34.Which sector does Astonea Labs Ltd (ASTONEALAB) belong to?
Astonea Labs Ltd (ASTONEALAB) belongs to the Health Care sector & Pharmaceuticals sub-sector.How to buy Astonea Labs Ltd (ASTONEALAB) shares?
You can directly buy Astonea Labs Ltd (ASTONEALAB) shares on Tickertape. Simply sign up, connect your demat account and place your order.
Astonea Labs Ltd
ASTONEALAB Share Price
BSE₹344.502.82% (-10.00)
High
—
—
Low
—
—
Returns
—
—
1D
1W
1M
1Y
5Y
Max
SIP
1D
1W
1M
1Y
5Y
Max
SIP
ASTONEALAB Stock Scorecard
Performance
AvgPrice return has been average, nothing exciting
Valuation
HighSeems to be overvalued vs the market average
Growth
AvgFinancials growth has been moderate for a few years
Profitability
AvgAverage profitability - not good, not bad
Entry point
AvgThe stock is not in the overbought zone
Red flags
LowNo red flag found
How to use scorecard? Learn more
ASTONEALAB Performance & Key Metrics
ASTONEALAB Performance & Key Metrics
| No LabelNo Label | PB RatioPB Ratio | Dividend YieldDiv. Yield |
|---|---|---|
| — | 6.34 | — |
| Sector PESector PE | Sector PBSector PB | Sector Div YldSctr Div Yld |
|---|---|---|
| 47.66 | 5.98 | 0.47% |
ASTONEALAB Analyst Ratings & Forecast
—
Analyst Ratings data is currently unavailable for this stockPrice Upside
Earnings Growth
Rev. Growth
ASTONEALAB Company Profile
Astonea Labs Ltd specializes in manufacturing and marketing pharmaceutical and cosmetic products, including antibiotics, anti-cold medications, and skin care items, with exports to Iraq and Yemen.
SUNPHARMA
PE Ratio
39.06
39.06
1Y Return
13.68%
13.68%
Buy Reco %
93.33
93.33
TORNTPHARM
PE Ratio
87.38
87.38
1Y Return
35.94%
35.94%
Buy Reco %
81.48
81.48
ZYDUSLIFE
PE Ratio
22.98
22.98
1Y Return
12.10%
12.10%
Buy Reco %
55.56
55.56
CIPLA
PE Ratio
28.87
28.87
1Y Return
10.12%
10.12%
Buy Reco %
62.86
62.86
LAURUSLABS
PE Ratio
122.65
122.65
1Y Return
123.22%
123.22%
Buy Reco %
58.33
58.33
ASTONEALAB Forecast
ASTONEALAB Forecasts
Forecast data is currently unavailable
Forecast data is currently unavailable
Price
Price Upside
Revenue
Revenue Growth
Earnings
Earnings Per Share
ASTONEALAB
ASTONEALAB
Income
Balance Sheet
Cash Flow
Quarterly Normal View
ASTONEALAB Income Statement
ASTONEALAB Income Statement
Quarterly Normal View
Hmm, looks like data is unavailable here. Please come back after some timeASTONEALAB Company Updates
ASTONEALAB Stock Peers
ASTONEALAB Past Performance & Peer Comparison
ASTONEALAB Past Performance & Peer Comparison
Comparing 3 stocks from
Health CarePharmaceuticals
Compare valuation on Screener
Health CarePharmaceuticals
Valuation
Technical
Forecast
Compare valuation on Screener| Stock | PE RatioPE Ratio | PB RatioPB Ratio | Div. YieldDividend Yield |
|---|---|---|---|
| Astonea Labs Ltd | 80.29 | 6.34 | — |
| Sun Pharmaceutical Industries Ltd | 39.06 | 5.35 | 0.86% |
| Torrent Pharmaceuticals Ltd | 87.38 | 10.75 | 0.68% |
| Zydus Lifesciences Ltd | 22.98 | 3.91 | 0.09% |
ASTONEALAB Stock Price Comparison
Compare ASTONEALAB with any stock or ETFCompare ASTONEALAB with any stock or ETF
ASTONEALAB
ASTONEALAB Holdings
ASTONEALAB Shareholdings
ASTONEALAB Promoter Holdings Trend
ASTONEALAB Promoter Holdings Trend
ASTONEALAB Institutional Holdings Trend
ASTONEALAB Institutional Holdings Trend
No institutional holdings trend are available
ASTONEALAB Shareholding Pattern
ASTONEALAB Shareholding Pattern
ASTONEALAB Shareholding History
ASTONEALAB Shareholding History
Foreign Institutions
smallcases containing ASTONEALAB stock
smallcases containing ASTONEALAB stock
Looks like this stock is not in any smallcase yet.
ASTONEALAB Events
ASTONEALAB Events
ASTONEALAB Dividend Trend
No Dividends
Dividends are the portion of earnings that a company distributes to all its shareholders every year
ASTONEALAB has not given any dividends in last 5 years
Dividends
Corp. Actions
Announcements
Legal Orders
Dividends
ASTONEALAB Dividend Trend
No Dividends
Dividends are the portion of earnings that a company distributes to all its shareholders every year
ASTONEALAB has not given any dividends in last 5 years
ASTONEALAB Dividends
ASTONEALAB Dividends
Hmm, looks like data is unavailable here. Please come back after some timeASTONEALAB Stock News & Opinions
ASTONEALAB Stock News & Opinions
Articles & Videos
Corporate
Corporate
Astonea Labs terminated agreements with Astonea One and invested USD 10,000 in Astonea LLCAstonea Labs Ltd. approved the immediate termination of agreements with Astonea One Private Limited, superseding a previous deferral from July 24, 2026, and also approved an initial capital investment of up to USD 10,000 in its wholly-owned subsidiary, Astonea LLC, in Wyoming, USA. The company’s board also approved the incorporation of “LONGEVITY SCIENCE PRIVATE LIMITED” as a subsidiary, noting a correction is underway regarding the initially submitted name, and took on record the cost audit report for the financial year ended March 31, 2026.
1 week agoCapital Market - Live
Corporate
Corporate
Astonea Labs members approved changes to expand into pharmaceuticals, nutraceuticals, and healthcareAstonea Labs Limited, formerly Astonea Labs Private Limited, informed the BSE Limited that its members approved an alteration to the Object Clause of the company’s Memorandum of Association at the 9th Annual General Meeting held on August 21, 2026, to expand and align the company’s business activities in the pharmaceutical, nutraceutical, healthcare, ayurvedic and allied sectors, including manufacturing, processing, marketing, distribution and sale of related products through various channels such as retail, wholesale, institutional sales, e-commerce platforms and digital marketplaces.
1 month agoCapital Market - Live
Corporate
Corporate
Astonea Labs to hold AGMAstonea Labs announced that the 9th Annual General Meeting(AGM) of the company will be held on 21 August 2026.
1 month agoCapital Market - Live
Corporate
Corporate
Astonea Labs to table resultsAstonea Labs will hold a meeting of the Board of Directors of the Company on 24 July 2026.
2 months agoCapital Market - Live
Corporate
Corporate
Astonea Labs to conduct board meetingAstonea Labs will hold a meeting of the Board of Directors of the Company on 30 May 2026.
3 months agoCapital Market - Live
Corporate
Corporate
Astonea Labs to hold EGMAstonea Labs announced that an Extra Ordinary General Meeting (EGM) of the Company will be held on 27 March 2026.Powered by Capital Market - Live
6 months agoCapital Market - Live
Corporate
Corporate
Astonea Labs to hold board meetingAstonea Labs will hold a meeting of the Board of Directors of the Company on 27 February 2026.Powered by Capital Market - Live
6 months agoCapital Market - Live
Corporate
Corporate
Astonea Labs schedules AGMAstonea Labs announced that the 8th Annual General Meeting(AGM) of the company will be held on 27 December 2025.Powered by Capital Market - Live
9 months agoCapital Market - Live
Corporate
Corporate
Astonea Labs fixes board meeting dateAstonea Labs will hold a meeting of the Board of Directors of the Company on 3 December 2025.Powered by Capital Market - Live
9 months agoCapital Market - Live
Corporate
Corporate
Astonea Labs to announce Quarterly ResultAstonea Labs will hold a meeting of the Board of Directors of the Company on 10 November 2025.Powered by Capital Market - Live
10 months agoCapital Market - Live
In last 6 months, promoter holding in the company has almost stayed constant
Pledged promoter holdings is insignificant